Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Volumn 17, Issue 4 Suppl 2, 2011, Pages

  Naoyuki, Kamatani ^a   Shin, Fujimori ^b   Toshikazu, Hada ^b   Tatsuo, Hosoya ^b   Kenjiro, Kohri ^b   Toshitaka, Nakamura ^b   Takanori, Ueda ^b   Tetsuya, Yamamoto ^b   Hisashi, Yamanaka ^b   Yuji, Matsuzawa ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGOUT AGENT; FEBUXOSTAT; THIAZOLE DERIVATIVE; URIC ACID; XANTHINE OXIDASE;

ADULT; ARTICLE; BLOOD; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONGENITAL MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; ENAMEL; FEMALE; FOLLOW UP; GOUT; HUMAN; JAPAN; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; CENTRAL NERVOUS SYSTEM DISEASES; DENTAL ENAMEL; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GOUT; GOUT SUPPRESSANTS; HUMANS; JAPAN; KIDNEY DISEASES, CYSTIC; MALE; MIDDLE AGED; THIAZOLES; TREATMENT OUTCOME; URIC ACID; XANTHINE OXIDASE;

EID: 84864035050     PISSN: None     EISSN: 15367355     Source Type: Journal    
DOI: None     Document Type: Article

References (0)